-
Je něco špatně v tomto záznamu ?
Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells
L. Hunakova, E. Horvathova, K. Majerova, P. Bobal, J. Otevrel, J. Brtko,
Jazyk angličtina Země Švýcarsko
Typ dokumentu srovnávací studie, časopisecké články
Grantová podpora
APVV-15-0372
Agentúra na Podporu Výskumu a Vývoja
2/0084/16, 2/0092/16 and 1/0136/18
Scientific Grant Agency of the Ministry of Education of Slovak Republic and the Academy of Sciences
320/2018/FaF
IGA UVPS Brno
TRANSMED, ITMS: 26240120008 and ITMS: 26240220071 and TRANSMED 2, ITMS: 26240120030
Research & Development Operational Programme funded by the ERDF
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
30857277
DOI
10.3390/ijms20051198
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků MeSH
- isothiokyanatany chemie farmakologie MeSH
- lidé MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- MFC-7 buňky MeSH
- nádorové buněčné linie MeSH
- nádory prsu farmakoterapie genetika metabolismus MeSH
- organocínové sloučeniny chemie farmakologie MeSH
- poškození DNA účinky léků MeSH
- protinádorové látky chemie farmakologie MeSH
- retinoidní X receptory metabolismus MeSH
- trialkylcínové sloučeniny chemie farmakologie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
The cytotoxicity of two recently synthesized triorganotin isothiocyanate derivatives, nuclear retinoid X receptor ligands, was tested and compared in estrogen-receptor-positive MCF 7 and -negative MDA-MB-231 human breast carcinoma cell lines. A 48 h MTT assay indicated that tributyltin isothiocyanate (TBT-ITC) is more cytotoxic than triphenyltin isothiocyanate (TPT-ITC) in MCF 7 cells, and the same trend was observed in the MDA-MB-231 cell line. A comet assay revealed the presence of both crosslinks and increasing DNA damage levels after the 17 h treatment with both derivatives. Differences in cytotoxicity of TBT-ITC and TPT-ITC detected by FDA staining correspond to the MTT data, communicating more pronounced effects in MCF 7 than in the MDA-MB-231 cell line. Both derivatives were found to cause apoptosis, as shown by the mitochondrial membrane potential (MMP) depolarization and caspase-3/7 activation. The onset of caspase activation correlated with MMP dissipation and the total cytotoxicity more than with the amount of active caspases. In conclusion, our data suggest that the DNA damage induced by TBT-ITC and TPT-ITC treatment could underlie their cytotoxicity in the cell lines studied.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027728
- 003
- CZ-PrNML
- 005
- 20190815114630.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms20051198 $2 doi
- 035 __
- $a (PubMed)30857277
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hunakova, Luba $u Cancer Research Institute, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Luba.Hunakova@savba.sk.
- 245 10
- $a Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells / $c L. Hunakova, E. Horvathova, K. Majerova, P. Bobal, J. Otevrel, J. Brtko,
- 520 9_
- $a The cytotoxicity of two recently synthesized triorganotin isothiocyanate derivatives, nuclear retinoid X receptor ligands, was tested and compared in estrogen-receptor-positive MCF 7 and -negative MDA-MB-231 human breast carcinoma cell lines. A 48 h MTT assay indicated that tributyltin isothiocyanate (TBT-ITC) is more cytotoxic than triphenyltin isothiocyanate (TPT-ITC) in MCF 7 cells, and the same trend was observed in the MDA-MB-231 cell line. A comet assay revealed the presence of both crosslinks and increasing DNA damage levels after the 17 h treatment with both derivatives. Differences in cytotoxicity of TBT-ITC and TPT-ITC detected by FDA staining correspond to the MTT data, communicating more pronounced effects in MCF 7 than in the MDA-MB-231 cell line. Both derivatives were found to cause apoptosis, as shown by the mitochondrial membrane potential (MMP) depolarization and caspase-3/7 activation. The onset of caspase activation correlated with MMP dissipation and the total cytotoxicity more than with the amount of active caspases. In conclusion, our data suggest that the DNA damage induced by TBT-ITC and TPT-ITC treatment could underlie their cytotoxicity in the cell lines studied.
- 650 _2
- $a protinádorové látky $x chemie $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a nádory prsu $x farmakoterapie $x genetika $x metabolismus $7 D001943
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a poškození DNA $x účinky léků $7 D004249
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a isothiokyanatany $x chemie $x farmakologie $7 D017879
- 650 _2
- $a MFC-7 buňky $7 D061986
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a organocínové sloučeniny $x chemie $x farmakologie $7 D009947
- 650 _2
- $a retinoidní X receptory $x metabolismus $7 D047488
- 650 _2
- $a trialkylcínové sloučeniny $x chemie $x farmakologie $7 D014220
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Horvathova, Eva $u Cancer Research Institute, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Eva.Horvathova@savba.sk.
- 700 1_
- $a Majerova, Karolina $u Cancer Research Institute, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Karolina.Majerova@savba.sk.
- 700 1_
- $a Bobal, Pavel $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic. bobalp@vfu.cz.
- 700 1_
- $a Otevrel, Jan $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic. otevrelj@vfu.cz.
- 700 1_
- $a Brtko, Julius $u Institute of Experimental Endocrinology, BMC, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovak Republic. Julius.Brtko@savba.sk.
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 5 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30857277 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190815114858 $b ABA008
- 999 __
- $a ok $b bmc $g 1432877 $s 1066188
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 5 $e 20190309 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a APVV-15-0372 $p Agentúra na Podporu Výskumu a Vývoja
- GRA __
- $a 2/0084/16, 2/0092/16 and 1/0136/18 $p Scientific Grant Agency of the Ministry of Education of Slovak Republic and the Academy of Sciences
- GRA __
- $a 320/2018/FaF $p IGA UVPS Brno
- GRA __
- $a TRANSMED, ITMS: 26240120008 and ITMS: 26240220071 and TRANSMED 2, ITMS: 26240120030 $p Research & Development Operational Programme funded by the ERDF
- LZP __
- $a Pubmed-20190813